Your browser doesn't support javascript.
loading
Is Severe and Long-lasting Linezolid-induced Optic Neuropathy Reversible?
Lee, Seul; Kang, Bo Hyoung; Ryu, Won Yeol; Um, Soo Jung; Roh, Mee Sook; Son, Choonhee.
Afiliação
  • Lee S; Division of Pulmonology, Department of Internal Medicine, College of Medicine, Dong-A University, Korea.
  • Kang BH; Division of Pulmonology, Department of Internal Medicine, College of Medicine, Dong-A University, Korea.
  • Ryu WY; Department of Ophthalmology, College of Medicine, Dong-A University, Korea.
  • Um SJ; Division of Pulmonology, Department of Internal Medicine, College of Medicine, Dong-A University, Korea.
  • Roh MS; Department of Pathology, College of Medicine, Dong-A University, Korea.
  • Son C; Division of Pulmonology, Department of Internal Medicine, College of Medicine, Dong-A University, Korea.
Intern Med ; 57(24): 3611-3613, 2018 Dec 15.
Article em En | MEDLINE | ID: mdl-30101940
ABSTRACT
Linezolid is a useful drug for treating drug-resistant tuberculosis. However, the associated toxicities, especially optic neuritis, are a major obstacle for its long-term use. We recently experienced a case of severe optic and peripheral neuropathy during the treatment of multidrug-resistant tuberculosis. The treatment continued for 12 months despite severe optic and peripheral neuropathy. At eight months after the discontinuation of the drug, the optic neuropathy recovered, but the peripheral neuropathy did not. Considering the grave prognosis of drug-resistant tuberculosis, the continuation of linezolid despite neurotoxicity under close observation may be a suitable option.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças do Nervo Óptico / Tuberculose Resistente a Múltiplos Medicamentos / Linezolida / Antituberculosos Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças do Nervo Óptico / Tuberculose Resistente a Múltiplos Medicamentos / Linezolida / Antituberculosos Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article